UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.310

Sortiert nach

Discovery of novel thieno[2,3- d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure–activity relationships

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (2), p.305-308

2009

Volltextzugriff (PDF)

The Association between Staphylococcus aureus Strains Carrying Panton-Valentine Leukocidin Genes and the Development of Deep-Seated Follicular Infection

Clinical infectious diseases, 2005-02, Vol.40 (3), p.381-385

2005

Volltextzugriff (PDF)

Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, φSLT

Gene, 2001-05, Vol.268 (1-2), p.195-206

2001

Volltextzugriff (PDF)

A Novel Synthetic Approach to Very Late Antigen-4 Antagonist trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid via tert-Butyl trans-[(4S)-Methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate as a Key Intermediate

Chemical and Pharmaceutical Bulletin, 2011/05/01, Vol.59(5), pp.574-578

2011

Volltextzugriff (PDF)

An analogy of Jacobi's formula and its applications

Hokkaido mathematical journal, 2023-10, Vol.52 (3)

2023

Volltextzugriff (PDF)

Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697

Journal of antibiotics, 2017-02, Vol.70 (2), p.179-186

2017

Volltextzugriff (PDF)

A Concise Synthesis of a Very Late Antigen-4 Antagonist trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid via Reductive Etherification

Chemical and Pharmaceutical Bulletin, 2012/07/01, Vol.60(7), pp.882-886

2012

Volltextzugriff (PDF)

A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

Cellular physiology and biochemistry, 2016, Vol.39 (5), p.1905-1918

2016

Volltextzugriff (PDF)

Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Journal of medicinal chemistry, 2009-12, Vol.52 (24), p.7974-7992

2009

Volltextzugriff (PDF)

Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist

Bioorganic & medicinal chemistry, 2012-02, Vol.20 (3), p.1201-1212

2012

Volltextzugriff (PDF)

Integration of Micro-Light-Emitting-Diode Arrays and Silicon Driver for Heterogeneous Optoelectronic Integrated Circuit Device

Japanese Journal of Applied Physics, 2011-04, Vol.50 (4), p.04DG12-04DG12-4

2011

Volltextzugriff (PDF)

Formation of hydrotalcite in aqueous solutions and intercalation of ATP by anion exchange

Journal of colloid and interface science, 2006-08, Vol.300 (2), p.648-654

2006

Volltextzugriff (PDF)

Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists

Bioorganic & medicinal chemistry, 2006-04, Vol.14 (8), p.2725-2746

2006

Volltextzugriff (PDF)

An isolate of Prototheca wickerhamii from systemic canine protothecosis

Veterinary microbiology, 2006-12, Vol.118 (3), p.305-311

2006

Volltextzugriff (PDF)

Effect of Interfacial Microstructure on Mechanical Properties of Cold Pressure-Welded Al-Cu Joints Subjected to Annealing

Journal of materials engineering and performance, 2021-10, Vol.30 (10), p.7386-7396

2021

Volltextzugriff (PDF)

Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists

Bioorganic & medicinal chemistry, 2007-02, Vol.15 (4), p.1679-1693

2007

Volltextzugriff (PDF)

Artificial Nucleosides Possessing Metal Binding Sites at the 3‘- and 5‘-Positions of the Deoxyribose Moieties

Journal of organic chemistry, 2003-01, Vol.68 (2), p.331-338

2003

Volltextzugriff (PDF)

4-(Pyrrolidinyl)methoxybenzoic Acid Derivatives as a Potent, Orally Active VLA-4 Antagonist

Chemical and Pharmaceutical Bulletin, 2006, Vol.54(11), pp.1515-1529

2006

Volltextzugriff (PDF)

Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist

Bioorganic & medicinal chemistry letters, 2005-01, Vol.15 (1), p.41-45

2005

Volltextzugriff (PDF)

Component of Caramel Food Coloring, THI, Causes Lymphopenia Indirectly via a Key Metabolic Intermediate

Cell chemical biology, 2016-05, Vol.23 (5), p.555-560

2016

Volltextzugriff (PDF)

Visual Person Identification Using a Distance-dependent Appearance Model for a Person Following Robot

International journal of automation and computing, 2013-10, Vol.10 (5), p.438-446

2013

Volltextzugriff (PDF)

Integration of Micro-Light-Emitting-Diode Arrays and Silicon Driver for Heterogeneous Optoelectronic Integrated Circuit Device

Japanese Journal of Applied Physics, 2011-04, Vol.50 (4S), p.4

2011

Volltextzugriff (PDF)

A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

Cellular physiology and biochemistry, 2016-11, Vol.39 (5), p.1905-1918

2016

Volltextzugriff (PDF)

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

Bioorganic & medicinal chemistry, 2013-01, Vol.21 (1), p.42-61

2013

Volltextzugriff (PDF)

Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (2), p.305-308

2009

Volltextzugriff (PDF)

1 – 25 von 1.310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.017)
Mit Volltextzugriff
(1.214)

Publikationsform

Sprache

Englisch
(1.148)
Japanisch
(569)
Koreanisch
(2)
Deutsch
(2)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Discovery of novel thieno[2,3- d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure–activity relationships

The Association between Staphylococcus aureus Strains Carrying Panton-Valentine Leukocidin Genes and the Development of Deep-Seated Follicular Infection

Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, φSLT

An analogy of Jacobi's formula and its applications

Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697

A Concise Synthesis of a Very Late Antigen-4 Antagonist trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid via Reductive Etherification

A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist

Integration of Micro-Light-Emitting-Diode Arrays and Silicon Driver for Heterogeneous Optoelectronic Integrated Circuit Device

Formation of hydrotalcite in aqueous solutions and intercalation of ATP by anion exchange

Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists

An isolate of Prototheca wickerhamii from systemic canine protothecosis

Effect of Interfacial Microstructure on Mechanical Properties of Cold Pressure-Welded Al-Cu Joints Subjected to Annealing

Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists

Artificial Nucleosides Possessing Metal Binding Sites at the 3‘- and 5‘-Positions of the Deoxyribose Moieties

4-(Pyrrolidinyl)methoxybenzoic Acid Derivatives as a Potent, Orally Active VLA-4 Antagonist

Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist

Component of Caramel Food Coloring, THI, Causes Lymphopenia Indirectly via a Key Metabolic Intermediate

Visual Person Identification Using a Distance-dependent Appearance Model for a Person Following Robot

Integration of Micro-Light-Emitting-Diode Arrays and Silicon Driver for Heterogeneous Optoelectronic Integrated Circuit Device

A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure

Suchergebnisse filtern